RxSight, Inc. (RXST)
NASDAQ: RXST · Real-Time Price · USD
4.470
-0.140 (-3.04%)
At close: Nov 20, 2026, 4:00 PM EST
4.490
+0.020 (0.45%)
After-hours: Nov 20, 2026, 7:30 PM EST
RxSight Revenue
RxSight had revenue of $24.59M in the quarter ending September 30, 2026, a decrease of -18.97%. This brings the company's total for the last twelve months to $121.83M, down -14.26% year-over-year. In the year 2025, RxSight had annual revenue of $134.48M, down -3.89%. That makes RxSight the 21,269th largest company in the world by revenue and 3,168th in the United States.
Revenue (ttm)
$121.83M
Revenue Growth
-14.26%
P/S Ratio
1.54
Revenue / Employee
$264,269
Employees
461
Market Cap
187.42M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 134.48M | -5.45M | -3.89% |
| Dec 31, 2024 | 139.93M | 50.85M | 57.09% |
| Dec 31, 2023 | 89.08M | 40.07M | 81.77% |
| Dec 31, 2022 | 49.01M | 26.41M | 116.90% |
| Dec 31, 2021 | 22.59M | 7.92M | 53.92% |
| Dec 31, 2020 | 14.68M | 12.44M | 554.98% |
| Dec 31, 2019 | 2.24M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Orthofix Medical | 835.41M |
| Inogen | 355.06M |
| InfuSystem Holdings | 144.44M |
| NeuroPace | 106.75M |
| Standard BioTools | 84.43M |
| Electromed | 75.57M |
| TriSalus Life Sciences | 46.39M |
| SS Innovations International | 45.95M |
RXST News
- 2 days ago - RxSight, Inc. to Present at the Piper Sandler Healthcare Conference - GlobeNewsWire
- 17 days ago - RxSight price target lowered to $8 from $10 at Piper Sandler - TheFly
- 17 days ago - RxSight price target lowered to $5 from $7 at Stifel - TheFly
- 17 days ago - RxSight price target lowered to $6 from $9 at Wells Fargo - TheFly
- 18 days ago - RxSight reports Q3 EPS (21c), consensus (29c) - TheFly
- 18 days ago - RxSight says nearly doubling sales force, completed organizational restructuring - TheFly
- 18 days ago - RxSight Earnings Call Transcript: Q3 2026 - Transcripts
- 18 days ago - RxSight Earnings release: Q3 2026 - Filings